Board Meeting27 Jul 2026, 06:10 pm
Oxygenta Pharma Declares Un-audited Q1 FY27 Results
AI Summary
Oxygenta Pharmaceutical Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the appointment of M/s. PCR & Associates as Cost Auditors for FY 2026-27 and scheduled the Annual General Meeting for August 21, 2026. The POSH Committee of the Board was re-constituted.
Key Highlights
- Un-audited financial results for Q1 FY27 declared.
- M/s. PCR & Associates appointed as Cost Auditors for FY 2026-27.
- Annual General Meeting scheduled for August 21, 2026.
- POSH Committee re-constituted effective July 27, 2026.
Price Impact
More from OXYGENTAPH